Literature DB >> 29413482

Cervical cancer vaccine controversy in India.

Manjulika Das.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29413482     DOI： 10.1016/S1470-2045(18)30018-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  An integrative behavior theory derived model to assess factors affecting HPV vaccine acceptance using structural equation modeling.

Authors:  Abraham Degarege; Karl Krupp; Kristopher Fennie; Vijaya Srinivas; Tan Li; Dionne P Stephens; Purnima Madhivanan
Journal:  Vaccine       Date:  2019-01-14       Impact factor: 3.641

2.  The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.

Authors:  Mario Songane; Volker Grossmann
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

3.  India needs a resilient cancer program.

Authors:  Zarin I Pilakkadavath; Arathi P Rao; K Rajasekharan Nayar; Raman Kumar; Shaffi F Koya
Journal:  J Family Med Prim Care       Date:  2021-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.